Evidence map›Paper›PMID 25368120›Full record

ArticleDisease models & mechanisms2014

Huntingtin is required for ER-to-Golgi transport and for secretory vesicle fusion at the plasma membrane.

Hemma Brandstaetter, Antonina J Kruppa, Folma Buss

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Regulation of Mutant Huntingtin Mitochondrial Toxicity by Phosphomimetic Mutations within Its N-Terminal Region.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington's Disease.International journal of molecular sciences · 2022
    Review
  9. Review
  10. The role of the Golgi apparatus in disease (Review).International journal of molecular medicine · 2021
    Review
  11. Huntingtin: A Protein with a Peculiar Solvent Accessible Surface.International journal of molecular sciences · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  16. Huntingtin and the Synapse.Frontiers in cellular neuroscience · 2021
    Review
  17. Quantitative Flow Cytometry-Based Assays for Measuring Constitutive Secretion.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  18. Article
  19. Lipid headgroups alter huntingtin aggregation on membranes.Biochimica et biophysica acta. Biomembranes · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hemma BrandstaetterCambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK.
Antonina J KruppaCambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK.
Folma BussCambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK. fb207@cam.ac.uk.
University of Cambridge · GB

Funding

Medical Research Council MR/K000888/1Wellcome Trust 086743Wellcome Trust 100140
6 · The paper itself

Abstract

Huntingtin is a large membrane-associated scaffolding protein that associates with endocytic and exocytic vesicles and modulates their trafficking along cytoskeletal tracks. Although the progression of Huntington's disease is linked to toxic accumulation of mutant huntingtin protein, loss of wild-type huntingtin function might also contribute to neuronal cell death, but its precise function is not well understood. Therefore, we investigated the molecular role of huntingtin in exocytosis and observed that huntingtin knockdown in HeLa cells causes a delay in endoplasmic reticulum (ER)-to-Golgi transport and a reduction in the number of cargo vesicles leaving the trans-Golgi network. In addition, we found that huntingtin is required for secretory vesicle fusion at the plasma membrane. Similar defects in the early exocytic pathway were observed in primary fibroblasts from homozygous Htt(140Q/140Q) knock-in mice, which have the expansion inserted into the mouse huntingtin gene so lack wild-type huntingtin expression. Interestingly, heterozygous fibroblasts from a Huntington's disease patient with a 180Q expansion displayed no obvious defects in the early secretory pathway. Thus, our results highlight the requirement for wild-type huntingtin at distinct steps along the secretory pathway.

Indexed as

AnimalsCell MembraneDisease Models, AnimalEndoplasmic ReticulumFibroblastsGolgi ApparatusGreen Fluorescent ProteinsHeLa CellsHomozygoteHumansHuntingtin ProteinHuntington DiseaseMiceMicroscopy, FluorescenceNerve Tissue ProteinsNuclear ProteinsGreen Fluorescent ProteinsHTT protein, humanHtt protein, mouseHuntingtin ProteinNerve Tissue ProteinsNuclear ProteinsRNA, Small InterferingERExocytosisGolgiHuntingtinVesicle fusion

Identifiers

PMID25368120
PMCPMC4257002
OpenAlexW2160142552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.